{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Lake Forest",
      "address_1": "275 N Field Dr",
      "reason_for_recall": "Discoloration: Reconstituted solution may appear pink instead of colorless to pale yellow when stored per the labeled conditions.",
      "address_2": "",
      "product_quantity": "3,306 vials",
      "code_info": "Lot #: B032223AA; Exp: July 2016",
      "center_classification_date": "20141222",
      "distribution_pattern": "Nationwide",
      "state": "IL",
      "product_description": "Dacarbazine, Injection, USP, 200mg,  vials packaged in individual cartons, Rx only, Manufactured by Hospira Australia 1 Lexia Place, Mulgrave, Victoria Australia 3170. NDC 61703-327-22.",
      "report_date": "20141231",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Hospira Inc.",
      "recall_number": "D-0313-2015",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "69900",
      "termination_date": "20161215",
      "more_code_info": "",
      "recall_initiation_date": "20141125",
      "postal_code": "60045-2579",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}